Full Length Research Paper
References
| Association of Official Analytical Chemists (AOAC) (2001). Association of Official Analytical Chemists. Official Methods of Analysis (21st Ed.), Washington, USA. | ||||
| Azima K, Samina J (2002). Role of hyperprolactinemia in infertility. Pak. J. Med. Res. 41(3):23-29. | ||||
|
Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG (2000). Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 148(2-3):187-197. Crossref |
||||
|
Colao A, Di Sarno A, Guerra E, De Leo M (2006). Drug insight: Carbegoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nat. Clin. Pract. Endocrinol. Metab. 2(4):200-210. Crossref |
||||
|
Cos P, De Bruyne T, Hermans N, Apers S, Berghe DV, Vlietinck AJ (2004). Proanthocyanidins in health care: current and new trends. Curr. Med. Chem. 11(10):1345-1359. Crossref |
||||
|
Hamburger M, Hostettman K (1991). Bioactivity in Plants: The link between phytochemistry and medicine. Phytochemistry 30:3864-3874. Crossref |
||||
| Harborne JB (2005). Phytochemical Methods- A Guide to Modern Techniques of Plant Analysis (3rd ed.). Springer Pvt. Ltd., New Delhi, India. | ||||
| Harnafi H, Amrani S (2007). Flavonoids are potent phytochemicals in cardiovascular diseases prevention. Pharmacol. Rev. 1:193-202. | ||||
|
Hasani-Ranjibar S, Vahidi H, Taslimi S, Karimi N, Abdollahi M (2010). A systematic review on the efficacy of herbal medicines in the management of human drug-induced hyperprolactinemia: potential sources for the development of novel drugs. Int. J. Pharmacol. 6:691-695. Crossref |
||||
|
Huang WY, Cai YZ, Zhang Y (2010). Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr. Cancer 62(1):1-20. Crossref |
||||
| Just MJ, Recio MC, Giner RM, Cueller MU, Manez S, Billia AR, Rios JL (1998). Anti-inflammatory activity of unusual lupine saponins from Bupleurum fruticescens. 64:404-407. | ||||
|
Man S, Gao W, Zhang Y, Huang L, Liu C (2010). Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 81(7):703-714. Crossref |
||||
|
Mancini T, Casanueva FF, Giustina LA (2008). Hyperprolactinemia and prolactinomia. Endocrinol. Metab. Clin. North America 37:67-99. Crossref |
||||
|
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlecte JA, Wass JAH (2011). Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metabol. 96:2273-2288. Crossref |
||||
|
Narender T, Khaliq T, Purib A, Chanderb R (2006). Antidyslipidemic activity of furano-flavonoids isolated from Indigofera tinctoria. Bioorg. Med. Chem. Lett. 16: 3411-3414. Crossref |
||||
|
Nijveldt RJ, Nood EC, Hoorn PG, Norren K, Leeuwen PAM (2001). Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:418-425. Pubmed |
||||
| Obadoni BO, Ochuko PO (2002). Phytochemical Studies and Comparative Efficacy of the Crude Extracts of Some Haemostatic Plants In Edo and Delta States of Nigeria. Global J. Pure Appl. Sci. 8(2):203-208. | ||||
|
Oyedemi SO, Afolayan AJ (2011). Antibacterial and antioxidant activities of hydro-alcoholic stem bark extract of Schotia latifolia Jacq. Asian Pac J Trop Med. 4(12):952-8. Crossref |
||||
|
Oyedemi SO, Oyedemi BO, Arowosegbe S, Afolayan AJ (2012). Phytochemical analysis and medicinal potentials of hydro-alcoholic extract from Curtisia dentate stem bark. Int. J. Mol. Sci. 13:6189-6203. Crossref |
||||
|
Prelevic GM, Wurzburger MI, Preric LJA (1987). Acute effects of L-dopa and bromocriptine on serim PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome. J. Endocrinol. Invest. 10:389-395. Crossref |
||||
| Robin D (2001). Nymphaea odorata: White pond lily. Medical Herbalism. Material Med. Pharm. 11:231-233. | ||||
|
Serri O, Chik C, Ur E, Ezzat S (2003). Diagnosis and management of hypreprolactinemia. CMAJ 169(6):575-581. Pubmed |
||||
| Siddhanta AK, Moody KH, Ramavat BK, Chauhan VD, Garg, HS, Goel, AK, Doss MJ, Srivastava MN, Patnaik GK, Kamboj VP (1997). Bioactivity of marine organisms: VIII- Screening of some marine flora of western coast of India. Indian J. Exp. Biol. 36:638-643. | ||||
|
Sofowora A (1993). Medicinal plants and traditional medicine in Africa (2nd Edition). Spectrum Books Limited, Ibadan, Nigeria. Pubmed |
||||
| Thorner MO, Marcello DB (2007). Hyperprolactinemia. J. Endocrinol. Metab. 25:1-15. | ||||
| Torre LD, Falorni M (2007). Pharmacological causes of hyperprolactinemia. Ther. Clin. Manag. 31(5):929-951. | ||||
|
Yamada K, Kanba S, Yagi G, Asai M (1997). Effectiveness of herbal medicine (shakuyaku-kanzo-to) in the treatment of neuroleptic-induced hyperprolactinemia. J. Clin. Psychopharmacol. 17:234-235. Crossref |
||||
|
Yamada K, Yagi G, Asai M (1999). Herbal medicine (shakuyaku-kanzo-to) in the treatment of reperidone-induced amenorrhea. J. Clin. Psychopharmacol. 19:380-381. Crossref |
||||
|
Yuah HN, Wang CW, Sze Y, Tan QR (2008). A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. J. Clin. Psychopharmacol. 28:264-270. Crossref |
||||
|
Zovko KM, Kremer D, Karlović K, Kosalec I (2008). Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat. Food Chem Toxicol. 48(8-9):2176-80. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
